Fred Graff, Chief Commercial Officer at Recro Pharma, Inc. (REPH), bought 8,000 shares at $8.46 ($68K) on 2016-05-31, disclosed to the SEC on 2016-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.